Harpoon Therapeutics Stock Net Asset
| HARPDelisted Stock | USD 0.85 0.00 0.00% |
Harpoon Therapeutics fundamentals help investors to digest information that contributes to Harpoon Therapeutics' financial success or failures. It also enables traders to predict the movement of Harpoon Stock. The fundamental analysis module provides a way to measure Harpoon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harpoon Therapeutics stock.
Harpoon |
Harpoon Therapeutics Company Net Asset Analysis
Harpoon Therapeutics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Harpoon Therapeutics Net Asset | 73.73 M |
Most of Harpoon Therapeutics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harpoon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Harpoon Therapeutics has a Net Asset of 73.73 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Harpoon Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harpoon Therapeutics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harpoon Therapeutics could also be used in its relative valuation, which is a method of valuing Harpoon Therapeutics by comparing valuation metrics of similar companies.Harpoon Therapeutics is currently under evaluation in net asset category among its peers.
Harpoon Fundamentals
| Return On Equity | -2.84 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (2.73) % | |||
| Current Valuation | 475.25 M | |||
| Shares Outstanding | 21.4 M | |||
| Shares Owned By Insiders | 0.34 % | |||
| Shares Owned By Institutions | 82.85 % | |||
| Number Of Shares Shorted | 1.16 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 108.42 X | |||
| Price To Sales | 13.19 X | |||
| Revenue | 37.34 M | |||
| Gross Profit | (49.48 M) | |||
| EBITDA | (35.45 M) | |||
| Net Income | (30.5 M) | |||
| Cash And Equivalents | 90.15 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 16.01 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 1.10 X | |||
| Cash Flow From Operations | (69.38 M) | |||
| Short Ratio | 0.37 X | |||
| Earnings Per Share | (8.62) X | |||
| Target Price | 23.67 | |||
| Number Of Employees | 53 | |||
| Beta | 2.1 | |||
| Market Capitalization | 492.35 M | |||
| Total Asset | 73.73 M | |||
| Retained Earnings | (352.52 M) | |||
| Working Capital | 2.29 M | |||
| Current Asset | 119.62 M | |||
| Current Liabilities | 18.4 M | |||
| Z Score | 10.72 | |||
| Net Asset | 73.73 M |
About Harpoon Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harpoon Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harpoon Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harpoon Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Harpoon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harpoon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harpoon Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Harpoon Stock
| 0.71 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.56 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.54 | TCHH | Trustcash Holdings | PairCorr |
| 0.52 | EC | Ecopetrol SA ADR | PairCorr |
| 0.49 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Harpoon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Harpoon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Harpoon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Harpoon Therapeutics to buy it.
The correlation of Harpoon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Harpoon Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Harpoon Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Harpoon Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |